Bill Texts: NJ S919 | 2020-2021 | Regular Session

Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2020-01-27 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee [S919 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2020-01-27HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey S919

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New Jersey S919 currently on file.

Social Comments on NJ S919

feedback